Search results
Results From The WOW.Com Content Network
Finerenone. Finerenone, sold under the brand name Kerendia and Firialta, is a medication used to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart attacks, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes. [8]
By Jonathan Stempel (Reuters) - Bayer won a legal victory in its fight to limit liability from claims its Roundup weed killer causes cancer, as a U.S. appeals court said on Thursday that federal ...
This marks the third trial loss for Bayer this month, after being hit by a $175 million verdict and a $1.25 million verdict in two separate Roundup trials. Before that, it had won nine consecutive ...
Esaxerenone (INN) (brand name Minnebro; developmental code names CS-3150, XL-550) is a nonsteroidal antimineralocorticoid which was discovered by Exelixis and developed by Daiichi Sankyo Company and is approved in Japan for the treatment of hypertension. [1][2][3] It acts as a highly selective silent antagonist of the mineralocorticoid receptor ...
February 5, 2024 at 5:41 PM. By Brendan Pierson. (Reuters) -A U.S. appeals court on Monday refused to dismiss a Georgia doctor's lawsuit claiming that Bayer AG's Roundup weedkiller caused cancer ...
Johnson v. Monsanto Co. was the first lawsuit to proceed to trial over Monsanto 's Roundup herbicide product causing cancer. The lawsuit alleged that the exposure of glyphosate, an active ingredient in the Roundup product, caused Dewayne "Lee" Johnson's non-Hodgkin lymphoma. In a landmark verdict, Monsanto's purchaser Bayer Corporation was ...
September 9, 2024 at 10:22 AM. (Reuters) -Rezolute Inc said on Monday the U.S. Food and Drug Administration had lifted its partial clinical hold on a late-stage study testing the company's ...
List of largest biomedical companies by revenue. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. It does not include biotechnology companies that ...